Pakistan’s capacity to effectively respond to the HIV epidemic could be hindered due to the lack of resources to implement its revised National Strategic Framework. The framework, endorsed by partners involved in the response, provides evidence-based strategic direction to urgently address the increasing levels of HIV infection amongst injecting drug users (IDUs) and other populations through sexual transmission and avoid a spillover to the general population.
Despite having an HIV prevalence of less than 0.1% among its general population, Pakistan’s HIV epidemic has transitioned from low to a concentrated one as the overall prevalence among IDUs has steadily increased from 10.8% in 2005 to nearly 21% in 2008.
In part, the region’s comparatively heavy burden of injecting drug use stems from the presence of long-standing trafficking routes for illicit opium. Opiates are the drug of choice for 65% of Asia’s drug rehabilitation patients, although drug use patterns vary greatly within the region. There are an estimated 91, 000 injecting drug users in Pakistan of which nearly one in four in large urban settings are infected with HIV.
 |
Syringe Exchange Programs and Drug Harm Reduction including detoxification programs for IDUs are a priority in light of the epidemic trends among IDUs. Substantial scale-up of harm reduction and HIV prevention services started around 2002-2004 and the country is now set to pilot drug substitution among drug users. Harm reduction services are being implemented by partner NGOs which can play a pivotal role in reaching out and expanding the provision of such services.
Biological and behavioral surveillance studies have shown an increase in knowledge regarding HIV, increase in condom use and decreased sharing of syringes/needles among IDUs exposed to risk reduction program activities. However, coverage of these programs is still low. An increase in resources available would expand the provision of risk and harm reduction services that are producing positive results mitigating the spread of HIV among populations at higher risk. |